Walleye Capital
AZN icon

Walleye Capital’s AstraZeneca AZN Stock Holding History

Walleye Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7M Buy
43,367
+43,361
+722,683% +$7.23M 0.01% 1574
2026
Q2 		$1.14K Buy
6
+5
+500% +$940 ﹤0.01% 4605
2026
Q1 		$197 Sell
1
-217,697
-100% -$42M ﹤0.01% 4287
2025
Q4 		$40M Buy
217,698
+9,305
+4% +$1.63M 0.12% 95
2025
Q3 		$32M Buy
208,393
+20,626
+11% +$3.12M 0.12% 122
2025
Q2 		$26.2M Buy
187,767
+11,995
+7% +$1.68M 0.1% 155
2025
Q1 		$25.8M Sell
175,772
-6,468
-4% -$936K 0.12% 146
2024
Q4 		$23.9M Sell
182,240
-54,251
-23% -$7.6M 0.06% 275
2024
Q3 		$36.9M Buy
236,491
+49,348
+26% +$7.97M 0.08% 168
2024
Q2 		$29.2M Buy
187,143
+56,621
+43% +$8.52M 0.05% 234
2024
Q1 		$17.7M Sell
130,522
-12,440
-9% -$1.65M 0.03% 485
2023
Q4 		$19.3M Sell
142,962
-40,083
-22% -$5.21M 0.04% 345
2023
Q3 		$24.8M Buy
+183,045
New +$25M 0.06% 190
2019
Q2 		– Sell
-327
Closed -$26K – 1725
2019
Q1 		$26K Buy
+327
New +$25.8K ﹤0.01% 1316

Other funds holding AZN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $162B AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Walleye Capital's AZN Position: Q3 2026 in Review

Walleye Capital increased its AstraZeneca (AZN) stake by 722,683% in Q3 2026, buying an estimated $7.23M and bringing the position to 43,367 shares worth $7M. The position accounts for 0.01% of the portfolio, ranked #1574.

Walleye Capital first reported a position in AZN in Q1 2019 and has held it in 14 quarters since. The position peaked at $40M in Q4 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Walleye Capital held 43,367 shares of AstraZeneca worth $7M as of Q3 2026.
  • Walleye Capital bought 43,361 AstraZeneca shares in Q3 2026, an estimated $7.23M.
  • AstraZeneca made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1574 holding.
  • Walleye Capital first reported a position in AstraZeneca in Q1 2019 and has held it in 14 quarters since.
  • Walleye Capital's AstraZeneca position peaked at $40M in Q4 2025.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.